Candriam Equities L Oncology Impact, N - Capitalisation/  LU2346866317  /

Fonds
NAV2024-06-10 Chg.+1.0100 Type of yield Investment Focus Investment company
159.3800EUR +0.64% reinvestment Equity Worldwide Candriam